Chapter/Section Purchase

1 Study Coverage
1.1 Medical Hemostatic Agents Product Introduction
1.2 Market by Type
1.2.1 Global Medical Hemostatic Agents Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Gelation Hemostats
1.2.3 Combination Hemostats
1.2.4 Others
1.3 Market by Application
1.3.1 Global Medical Hemostatic Agents Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Medical Hemostatic Agents Sales Estimates and Forecasts 2017-2028
2.2 Global Medical Hemostatic Agents Revenue Estimates and Forecasts 2017-2028
2.3 Global Medical Hemostatic Agents Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Medical Hemostatic Agents Sales by Region
2.4.1 Global Medical Hemostatic Agents Sales by Region (2017-2022)
2.4.2 Global Sales Medical Hemostatic Agents by Region (2023-2028)
2.5 Global Medical Hemostatic Agents Revenue by Region
2.5.1 Global Medical Hemostatic Agents Revenue by Region (2017-2022)
2.5.2 Global Medical Hemostatic Agents Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Medical Hemostatic Agents Sales by Manufacturers
3.1.1 Global Top Medical Hemostatic Agents Manufacturers by Sales (2017-2022)
3.1.2 Global Medical Hemostatic Agents Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Medical Hemostatic Agents in 2021
3.2 Global Medical Hemostatic Agents Revenue by Manufacturers
3.2.1 Global Medical Hemostatic Agents Revenue by Manufacturers (2017-2022)
3.2.2 Global Medical Hemostatic Agents Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Medical Hemostatic Agents Revenue in 2021
3.3 Global Medical Hemostatic Agents Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Medical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Medical Hemostatic Agents Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Medical Hemostatic Agents Sales by Type
4.1.1 Global Medical Hemostatic Agents Historical Sales by Type (2017-2022)
4.1.2 Global Medical Hemostatic Agents Forecasted Sales by Type (2023-2028)
4.1.3 Global Medical Hemostatic Agents Sales Market Share by Type (2017-2028)
4.2 Global Medical Hemostatic Agents Revenue by Type
4.2.1 Global Medical Hemostatic Agents Historical Revenue by Type (2017-2022)
4.2.2 Global Medical Hemostatic Agents Forecasted Revenue by Type (2023-2028)
4.2.3 Global Medical Hemostatic Agents Revenue Market Share by Type (2017-2028)
4.3 Global Medical Hemostatic Agents Price by Type
4.3.1 Global Medical Hemostatic Agents Price by Type (2017-2022)
4.3.2 Global Medical Hemostatic Agents Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Medical Hemostatic Agents Sales by Application
5.1.1 Global Medical Hemostatic Agents Historical Sales by Application (2017-2022)
5.1.2 Global Medical Hemostatic Agents Forecasted Sales by Application (2023-2028)
5.1.3 Global Medical Hemostatic Agents Sales Market Share by Application (2017-2028)
5.2 Global Medical Hemostatic Agents Revenue by Application
5.2.1 Global Medical Hemostatic Agents Historical Revenue by Application (2017-2022)
5.2.2 Global Medical Hemostatic Agents Forecasted Revenue by Application (2023-2028)
5.2.3 Global Medical Hemostatic Agents Revenue Market Share by Application (2017-2028)
5.3 Global Medical Hemostatic Agents Price by Application
5.3.1 Global Medical Hemostatic Agents Price by Application (2017-2022)
5.3.2 Global Medical Hemostatic Agents Price Forecast by Application (2023-2028)
6 North America
6.1 North America Medical Hemostatic Agents Market Size by Type
6.1.1 North America Medical Hemostatic Agents Sales by Type (2017-2028)
6.1.2 North America Medical Hemostatic Agents Revenue by Type (2017-2028)
6.2 North America Medical Hemostatic Agents Market Size by Application
6.2.1 North America Medical Hemostatic Agents Sales by Application (2017-2028)
6.2.2 North America Medical Hemostatic Agents Revenue by Application (2017-2028)
6.3 North America Medical Hemostatic Agents Market Size by Country
6.3.1 North America Medical Hemostatic Agents Sales by Country (2017-2028)
6.3.2 North America Medical Hemostatic Agents Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Medical Hemostatic Agents Market Size by Type
7.1.1 Europe Medical Hemostatic Agents Sales by Type (2017-2028)
7.1.2 Europe Medical Hemostatic Agents Revenue by Type (2017-2028)
7.2 Europe Medical Hemostatic Agents Market Size by Application
7.2.1 Europe Medical Hemostatic Agents Sales by Application (2017-2028)
7.2.2 Europe Medical Hemostatic Agents Revenue by Application (2017-2028)
7.3 Europe Medical Hemostatic Agents Market Size by Country
7.3.1 Europe Medical Hemostatic Agents Sales by Country (2017-2028)
7.3.2 Europe Medical Hemostatic Agents Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Medical Hemostatic Agents Market Size by Type
8.1.1 Asia Pacific Medical Hemostatic Agents Sales by Type (2017-2028)
8.1.2 Asia Pacific Medical Hemostatic Agents Revenue by Type (2017-2028)
8.2 Asia Pacific Medical Hemostatic Agents Market Size by Application
8.2.1 Asia Pacific Medical Hemostatic Agents Sales by Application (2017-2028)
8.2.2 Asia Pacific Medical Hemostatic Agents Revenue by Application (2017-2028)
8.3 Asia Pacific Medical Hemostatic Agents Market Size by Region
8.3.1 Asia Pacific Medical Hemostatic Agents Sales by Region (2017-2028)
8.3.2 Asia Pacific Medical Hemostatic Agents Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Medical Hemostatic Agents Market Size by Type
9.1.1 Latin America Medical Hemostatic Agents Sales by Type (2017-2028)
9.1.2 Latin America Medical Hemostatic Agents Revenue by Type (2017-2028)
9.2 Latin America Medical Hemostatic Agents Market Size by Application
9.2.1 Latin America Medical Hemostatic Agents Sales by Application (2017-2028)
9.2.2 Latin America Medical Hemostatic Agents Revenue by Application (2017-2028)
9.3 Latin America Medical Hemostatic Agents Market Size by Country
9.3.1 Latin America Medical Hemostatic Agents Sales by Country (2017-2028)
9.3.2 Latin America Medical Hemostatic Agents Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Medical Hemostatic Agents Market Size by Type
10.1.1 Middle East and Africa Medical Hemostatic Agents Sales by Type (2017-2028)
10.1.2 Middle East and Africa Medical Hemostatic Agents Revenue by Type (2017-2028)
10.2 Middle East and Africa Medical Hemostatic Agents Market Size by Application
10.2.1 Middle East and Africa Medical Hemostatic Agents Sales by Application (2017-2028)
10.2.2 Middle East and Africa Medical Hemostatic Agents Revenue by Application (2017-2028)
10.3 Middle East and Africa Medical Hemostatic Agents Market Size by Country
10.3.1 Middle East and Africa Medical Hemostatic Agents Sales by Country (2017-2028)
10.3.2 Middle East and Africa Medical Hemostatic Agents Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 J&J
11.1.1 J&J Corporation Information
11.1.2 J&J Overview
11.1.3 J&J Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 J&J Medical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 J&J Recent Developments
11.2 Baxter
11.2.1 Baxter Corporation Information
11.2.2 Baxter Overview
11.2.3 Baxter Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Baxter Medical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Baxter Recent Developments
11.3 BD
11.3.1 BD Corporation Information
11.3.2 BD Overview
11.3.3 BD Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 BD Medical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BD Recent Developments
11.4 Gelita
11.4.1 Gelita Corporation Information
11.4.2 Gelita Overview
11.4.3 Gelita Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Gelita Medical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Gelita Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Medical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 B Braun
11.6.1 B Braun Corporation Information
11.6.2 B Braun Overview
11.6.3 B Braun Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 B Braun Medical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 B Braun Recent Developments
11.7 CSL Behring
11.7.1 CSL Behring Corporation Information
11.7.2 CSL Behring Overview
11.7.3 CSL Behring Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 CSL Behring Medical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 CSL Behring Recent Developments
11.8 Ferrosan Medical Devices
11.8.1 Ferrosan Medical Devices Corporation Information
11.8.2 Ferrosan Medical Devices Overview
11.8.3 Ferrosan Medical Devices Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Ferrosan Medical Devices Medical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Ferrosan Medical Devices Recent Developments
11.9 Advance Medical Solution
11.9.1 Advance Medical Solution Corporation Information
11.9.2 Advance Medical Solution Overview
11.9.3 Advance Medical Solution Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Advance Medical Solution Medical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Advance Medical Solution Recent Developments
11.10 Medtronic
11.10.1 Medtronic Corporation Information
11.10.2 Medtronic Overview
11.10.3 Medtronic Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Medtronic Medical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Medtronic Recent Developments
11.11 Z-Medica
11.11.1 Z-Medica Corporation Information
11.11.2 Z-Medica Overview
11.11.3 Z-Medica Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Z-Medica Medical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Z-Medica Recent Developments
11.12 Marine Polymer
11.12.1 Marine Polymer Corporation Information
11.12.2 Marine Polymer Overview
11.12.3 Marine Polymer Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Marine Polymer Medical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Marine Polymer Recent Developments
11.13 Equimedical
11.13.1 Equimedical Corporation Information
11.13.2 Equimedical Overview
11.13.3 Equimedical Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Equimedical Medical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Equimedical Recent Developments
11.14 CryoLife
11.14.1 CryoLife Corporation Information
11.14.2 CryoLife Overview
11.14.3 CryoLife Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 CryoLife Medical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 CryoLife Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Medical Hemostatic Agents Industry Chain Analysis
12.2 Medical Hemostatic Agents Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Medical Hemostatic Agents Production Mode & Process
12.4 Medical Hemostatic Agents Sales and Marketing
12.4.1 Medical Hemostatic Agents Sales Channels
12.4.2 Medical Hemostatic Agents Distributors
12.5 Medical Hemostatic Agents Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Medical Hemostatic Agents Industry Trends
13.2 Medical Hemostatic Agents Market Drivers
13.3 Medical Hemostatic Agents Market Challenges
13.4 Medical Hemostatic Agents Market Restraints
14 Key Findings in The Global Medical Hemostatic Agents Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer